Free Trial

Capital City Trust Co. FL Invests $1.95 Million in CME Group Inc. $CME

CME Group logo with Finance background

Key Points

  • Capital City Trust Co. FL invested approximately $1.95 million in CME Group Inc., acquiring 7,074 shares according to their recent Form 13F filing.
  • Notable institutional investors like GQG Partners LLC and Wellington Management Group LLP significantly increased their holdings in CME by over 370% in the last quarter.
  • CME Group recently declared a quarterly dividend of $1.25, equating to a 1.9% dividend yield, with a payout ratio of 48.40%.
  • MarketBeat previews the top five stocks to own by November 1st.

Capital City Trust Co. FL acquired a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,074 shares of the financial services provider's stock, valued at approximately $1,950,000.

A number of other institutional investors have also recently made changes to their positions in CME. GQG Partners LLC boosted its position in shares of CME Group by 7,676.3% in the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock worth $584,975,000 after purchasing an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock worth $704,068,000 after purchasing an additional 2,089,935 shares in the last quarter. Nuveen LLC acquired a new stake in shares of CME Group in the 1st quarter worth $218,842,000. Alliancebernstein L.P. boosted its position in shares of CME Group by 185.5% in the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider's stock worth $330,182,000 after purchasing an additional 808,740 shares in the last quarter. Finally, Egerton Capital UK LLP boosted its position in shares of CME Group by 79.4% in the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock worth $459,003,000 after purchasing an additional 765,773 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard purchased 262 shares of the business's stock in a transaction that occurred on Thursday, September 25th. The stock was purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director directly owned 258,459 shares in the company, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business's stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company's stock, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock worth $3,527,956 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

Shares of CME stock opened at $264.67 on Friday. The stock has a market cap of $95.38 billion, a PE ratio of 25.62, a price-to-earnings-growth ratio of 5.57 and a beta of 0.41. The business has a 50-day simple moving average of $269.98 and a 200-day simple moving average of $271.13. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the business earned $2.56 EPS. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. On average, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group's payout ratio is currently 48.40%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CME. Morgan Stanley lifted their price target on CME Group from $303.00 to $312.00 and gave the stock an "overweight" rating in a research report on Wednesday. Weiss Ratings reaffirmed a "buy (b)" rating on shares of CME Group in a research report on Saturday, September 27th. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Oppenheimer lifted their price target on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Finally, Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, CME Group currently has a consensus rating of "Hold" and an average target price of $274.15.

Check Out Our Latest Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.